Država: Nizozemska
Jezik: nizozemski
Izvor: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
XYLOMETAZOLINEHYDROCHLORIDE 0,5 mg/ml SAMENSTELLING overeenkomend met ; XYLOMETAZOLINE 0,43 mg/ml
Pharmachemie B.V. Swensweg 5 2031 GA HAARLEM
R01AA07
XYLOMETAZOLINEHYDROCHLORIDE 0,5 mg/ml SAMENSTELLING overeenkomend met ; XYLOMETAZOLINE 0,43 mg/ml
Neusspray, oplossing
CITROENZUUR 1-WATER (E 330) ; GLYCEROL 85 PER CENT (E 422) ; STIKSTOF (HEAD SPACE) (E 941) ; TRINATRIUMCITRAAT 2-WATER (E 331) ; WATER VOOR INJECTIE,
Nasaal gebruik
Xylometazoline
Hulpstoffen: CITROENZUUR 1-WATER (E 330); GLYCEROL 85 PER CENT (E 422); STIKSTOF (HEAD SPACE) (E 941); TRINATRIUMCITRAAT 2-WATER (E 331); WATER VOOR INJECTIE;
2012-09-18
Xylometazoline-NL/H/2223+2237/001-002-27.03.23 1 rvg 109042-3 EU PIL IB/011/G met NL info-tracked PACKAGE LEAFLET: INFORMATION FOR THE USER XYLOZOLIN 0,5 MG/ML, NEUSSPRAY, OPLOSSING Xylometazoline hydrochloride 0.5 mg/ml XYLOZOLIN 1 MG/ML, NEUSSPRAY, OPLOSSING_ _ Xylometazoline hydrochloride 1 mg/ml READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. • You must talk to a doctor if you do not feel better or if you feel worse after 7 days. WHAT IS IN THIS LEAFLET 1. What {(Invented) name strength pharmaceutical form} is and what it is used for 2. What you need to know before you use {(Invented) name strength pharmaceutical form} 3. How to use {(Invented) name strength pharmaceutical form} 4. Possible side effects 5. How to store {(Invented) name strength pharmaceutical form} 6. Contents of the pack and other information 1. WHAT {(INVENTED) NAME STRENGTH PHARMACEUTICAL FORM} IS AND WHAT IT IS USED FOR You must talk to a doctor if you do not feel better or if you feel worse after 7 days. {(Invented) name strength pharmaceutical form} contains the active ingredient xylometazoline, which is a topical decongestant that relieves nasal congestion. A decongestant reduces the swelling of the nasal mucosa. {(Invented) name strength pharmaceutical form} is used for temporary symptomatic treatment of nasal congestion due to rhinitis or sinusitis. {(INVENTED) NAME 0.5 MG/ML PHARMACEUTICAL FORM} IS INTENDED FOR CHILDREN BETWEEN 2 AND 10 YEARS OF AGE. {(INVENTED) NAME 1 MG/ML PHARMACEUTICAL FORM} IS INTENDED FOR ADULTS AS WELL AS FOR CHILDREN 10 YEARS OF AGE AND OLDER. 2. WHAT YOU NEED T Pročitajte cijeli dokument
Xylometazoline-NL/H/2223+2237/001-002-27.03.23 1 rvg 109042-3 EU SPC IB/011/G met NL info-tracked SUMMARY OF PRODUCT CHARACTERISTICS 1. NAAM VAN HET GENEESMIDDEL Xylozolin 0,5 mg/ml, neusspray, oplossing Xylozolin 1 mg/ml, neusspray, oplossing _ _ Xylometazoline hydrochloride 1 / 0.5 mg/ml 2. QUALITATIVE AND QUANTITATIVE COMPOSITION {(INVENTED) NAME 1 MG/ML PHARMACEUTICAL FORM} One actuation (equivalent to 0.09 ml nasal spray, solution) contains 0.09 mg xylometazoline hydrochloride. {(INVENTED) NAME 0.5 MG/ML PHARMACEUTICAL FORM} One actuation (equivalent to 0.09 ml nasal spray, solution) contains 0.045 mg xylometazoline hydrochloride. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Nasal spray, solution (nasal spray) Clear, almost colourless solution (pH 5.5-6; Osmolality 250-300 mOsm/kg). 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For temporary symptomatic treatment of nasal congestion due to rhinitis or sinusitis. {(INVENTED) NAME 1 MG/ML PHARMACEUTICAL FORM} is intended for adults as well as for children 10 years of age and older. {(INVENTED) NAME 0.5 MG/ML PHARMACEUTICAL FORM} is intended for children between 2 and 10 years of age. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology This medicinal product is intended for nasal use. {(INVENTED) NAME 1 MG/ML PHARMACEUTICAL FORM}: The dose in adults and children 10 years of age and older is 1-2 sprays of _{(Invented) name 1 mg/ml _ _pharmaceutical form}_ into each nostril, according to need, but up to a MAXIMUM of 3 times daily. Dosages higher than those recommended must not be used. {(INVENTED) NAME 1 MG/ML PHARMACEUTICAL FORM} is suitable for adults as well as for children over 10 years of age. It must not be used in children below 10 years of age. _ _ {(INVENTED) NAME 0.5 MG/ML PHARMACEUTICAL FORM}: The dose in children between 2 and 10 years of age is one spray of _{(Invented) name 0.5 mg/ml _ _pharmaceutical form}_ into each nostril, according to need, but up to a MAXIMUM of 3 times daily. Dosages higher than those recommen Pročitajte cijeli dokument